Information on the Total Number of Voting Rights (Denominator) Following the Completion of the LDA Capital Increase

Liege, Belgium, 05 August 2020 – 17:45 CEST –In accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions, Mithra Pharmaceuticals SA (the “Company” or “Mithra”) announces the below information, following the issuance of 159,800 new shares today for a total amount of EUR 3,104,869 following the First Put Option Notice issued on May 29 2020 in the framework of the formal completion of the Company’s capital increase approved by the Board on May 22, 2020 according to the terms of the LDA capital commitment agreement.